Amarin Corporation plc AMRN
11.71 USD -0.04 (-0.34%)
At closeNov 11, 2026, 4:00 PM EST
11.71 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
11.59 Day range 11.82
11.25 52-week range 17.31
- YTD
- -16.12%
- 1 year
- -27.22%
News
fool.com Amarin: 3 Key Takeaways for Long-Term Investors Amarin reported its first profitable quarter in two years during Q3. European in-market demand for VAZKEPA grew 68% year over year.
benzinga.com Amarin Presents New Clinical Data Evaluating Lipoprotein(A) And Other apoB Containing Lipoproteins As Predictors Of MACE, At AHA Scientific Sessions 2026 Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today highlighted new clinical data evaluating lipoprotein(a) [Lp(a)] and other…
globenewswire.com Amarin Highlights New Data on Lipoprotein(a) and other Apolipoprotein B Containing Lipoproteins at American Heart Association (AHA) Scientific Sessions 2026 DUBLIN and BRIDGEWATER, N.J., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today…
benzinga.com Amarin Corp Q3 2026 Earnings Call Transcript Amarin Corp (NASDAQ:AMRN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Amarin Corp Q3 Adj. EPS $0.08 Beats $(0.02) Estimate, Sales $39.550M Miss $43.711M Estimate Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.02) by 500 percent. This is a 57.89 percent decrease over earnings of $0.19…